Nile Pharma is planning to invest EGP 40 mn during the 2017-18 fiscal year to develop two production lines to increase output and boost revenues, Al Mal reports. The company plans to invest additional profit in enhancing its export capacity and financing the purchase of raw materials. Nile Pharma is eyeing new export markets in Africa and former Soviet Union countries to compensate for declining business with Libya, Yemen, and Iraq.

Tags: